Simultaneous determination of efavirenz, rifampicin and its metabolite desacetyl rifampicin levels in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 4, 2011, Pages 785-791

  Fox, Deirdre ^a   O'connor, Robert ^a   Mallon, Patrick ^b   Mcmahon, Gillian ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Desacetyl rifampicin; Efavirenz; HPLC UV; Plasma; Rifampicin; SPE

Indexed keywords

DEACETYLRIFAMPICIN; DRUG METABOLITE; EFAVIRENZ; RIFAMPICIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TUBERCULOSIS;

ANTI-HIV AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BENZOXAZINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; DRUG STABILITY; HIV INFECTIONS; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84860409941     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.07.041     Document Type: Article

References (17)

1. Joint United Nations Programme on HIV/AIDS, NetLibrary Inc., World Health Organization. AIDS epidemic update December 2005. Unaids, Geneva, Switzerland, 2005.
2. Ramachandran G., Kumar A.K.H., Swaminathan S., Venkatesan P., Kumaraswami V., Greenblatt D.J. Simple and rapid liquid chromatography method for determination of efavirenz in plasma. J. Chromatogr. B 2006, 835:131-135.
3. WHO Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource Limited Settings: Towards Universal Access. 2006 Revision 2006, World Health Organisation, Geneva.
4. Boffito M., Tija J., Reynolds H.E., Hoggard P.G., Bonora S., Di Perri G., Back D.J. Simultaneous determination of rifampicin and efavirenz in plasma. Ther. Drug Monit. 2002, 24:670-674.
5. Hartkoorn R.C., Khoo S., Back D.J., Tjia J.F., Waitt C.J., Chaponda M., Davies G., Ardrey A., Ashleigh S., Ward S.A. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. J. Chromatogr. B 2007, 857:76-82.
6. Balbão M.S., Bertucci C., Bergamaschi M.M., Queiroz R.H.C., Malfará W.R., Dreossi S.A.C., de Paula Mello L., Queiroz M.E.C. Rifampicin determination in plasma by stir bar-sorptive extraction and liquid chromatography. J. Pharm. Biomed. Anal. 2010, 51:1078-1083.
7. Mogatle S., Kanfer I. Rapid method for the quantitative determination of efavirenz in human plasma. J. Pharm. Biomed. Anal. 2009, 49:1308-1312.
8. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
9. D'Avolio A., Simiele M., Siccardi M., Baietto L., Sciandra M., Bonora S., Di Perri G. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. J. Pharm. Biomed. Anal. 2010, 52:774-780.
10. Swart K.J., Papgis M. Automated high-performance liquid chromatographic method for the determination of rifampicin in plasma. J. Chromatogr. 1992, 593:21-24.
11. Volosov A., Alexander C., Ting L., Soldin S.J. Simple rapid method for quantification of antiretrovirals by liquid chromatography-tandem mass-spectrometry. Clin. Biochem. 2002, 35:99-103.
12. Rezk N.L., Tidwell R.R., Kashuba A.D.M. Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 774:79-88.
13. Sarasa-Nacenta M., López-Púa Y., López-Cortés L.F., Mallolas J., Gatell J.M., Carné X. Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 763:53-59.
14. Marzolini C., Telenti A., Buclin T., Biollaz J., Decosterd L.A. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction. J. Chromatogr. B: Biomed. Sci. Appl. 2000, 740:43-58.
15. Allanson A.L, Cotton M.M., Tettey J.N.A., Boyter A.C. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring. J. Pharm. Biomed. Anal. 2007, 44:963-969.
16. Panchagnula R., Sood A., Sharda N., Kaur K., Kaul C.L. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. J. Pharm. Biomed. Anal. 1999, 18:1013-1020.
17. http://bioteachnology.com/dna/quantitative-estimation-of-dna-concentrations.